ARK Investment Management LLC

Source: SEC Form 13F · as of Mar 2026

ARK Investment Management LLC holds 25 biotech & pharma companies tracked by BioSniper, totaling $1.74B in value as of Mar 2026 (SEC Form 13F).

Companies held

25

Total value held

$1.74B

CompanySharesValue
CRSPCRISPR Therapeutics AG11,313,623$538.2M
TWSTTwist Bioscience Corp6,342,733$301.4M
BEAMBeam Therapeutics Inc.12,133,433$289.1M
NTLAIntellia Therapeutics, Inc.14,509,247$186.0M
RXRXRECURSION PHARMACEUTICALS, INC.40,212,769$123.5M
GHGuardant Health Inc.486,675$45.0M
ABSIAbsci Corporation13,726,169$41.2M
ADPTAdaptive Biotechnologies Corp2,092,969$29.1M
NRIXNurix Therapeutics, Inc.1,721,135$26.7M
SDGRSchrodinger, Inc.2,067,135$23.5M
PRMEPrime Medicine, Inc.6,246,827$21.7M
IONSIONIS PHARMACEUTICALS INC288,716$21.7M
ARCTArcturus Therapeutics Holdings Inc.2,769,518$21.4M
CMPSCOMPASS Pathways plc3,301,050$18.3M
CNTNCanton Strategic Holdings, Inc.3,695,084$12.1M
LLYELI LILLY & Co12,676$11.7M
BNTXBioNTech SE127,878$11.4M
GENBGenerate Biomedicines Inc.498,408$6.2M
CGENCOMPUGEN LTD1,049,873$2.2M
KMDAKAMADA LTD269,557$2.2M
MDWDMediWound Ltd.129,961$2.1M
URGNUroGen Pharma Ltd.115,545$2.1M
DRTSAlpha Tau Medical Ltd.292,134$2.1M
TEVATeva Pharmaceutical Industries Limited68,279$2.1M
ENLVEnlivex Ltd.628,310$584K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    ARK Investment Management LLC — Biotech 13F Holdings & Portfolio | BioSniper